These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 10700253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J, Dougherty JJ, Nichols RA.
    J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
    Cepeda C, André VM, Yamazaki I, Wu N, Kleiman-Weiner M, Levine MS.
    Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
    [Abstract] [Full Text] [Related]

  • 7. [D2-receptor antagonist blocks the dopamine effect on membranes of multipolar neurons of the ammocaete spinal cord].
    Bukinich AA, Veselkin NP.
    Zh Evol Biokhim Fiziol; 2007 Feb; 43(2):206-9. PubMed ID: 17674716
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
    Ramanathan S, Tkatch T, Atherton JF, Wilson CJ, Bevan MD.
    J Neurophysiol; 2008 Feb; 99(2):442-59. PubMed ID: 18094105
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
    Sasaki T, Kotera J, Omori K.
    J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phosphodiesterase 10A inhibitor, MP-10 (PF-2545920), produces greater induction of c-Fos in dopamine D2 neurons than in D1 neurons in the neostriatum.
    Wilson JM, Ogden AM, Loomis S, Gilmour G, Baucum AJ, Belecky-Adams TL, Merchant KM.
    Neuropharmacology; 2015 Dec; 99():379-86. PubMed ID: 26256420
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons.
    Ince E, Ciliax BJ, Levey AI.
    Synapse; 1997 Dec; 27(4):357-66. PubMed ID: 9372558
    [Abstract] [Full Text] [Related]

  • 19. Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation.
    Nishi A, Snyder GL, Fienberg AA, Fisone G, Aperia A, Nairn AC, Greengard P.
    Eur J Neurosci; 1999 Jul; 11(7):2589-92. PubMed ID: 10383649
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.